U.S. Market Entry & Launch Readiness

What's typically included

• Market-entry assessment — senior read on whether the U.S. is the right market for this product, in this form, on this timeline, and what the credible alternatives are.
• Regulatory & quality requirement mapping — identifying the U.S.-specific regulatory, classification, labeling, and quality requirements the product must meet, and where the current dossier or operation falls short.
• Retailer considerations — practical guidance on what major U.S. retailers and channels expect for the product category, from quality and documentation to claims and labeling.
• Launch-readiness roadmap — a sequenced plan of the regulatory, quality, supply, and commercial work needed to launch, with the dependencies and decision points called out.
• Commercialization recommendations — practical input on positioning, channel sequencing, and the trade-offs between speed, scope, and risk at launch.

When this is the right conversation

Companies typically engage RGM here when a non-U.S. organization is evaluating U.S. entry; when a U.S. company is moving an existing product into a new channel or retailer with different expectations; when a launch date is on the calendar and the team needs to know whether it is realistic; or when an early launch attempt stalled and leadership wants a senior read on why.

Output you can use

A market-entry assessment that names the right next move and the reasoning behind it. A launch-readiness roadmap that ties regulatory, quality, and commercial work to a credible timeline. A documented view of the gaps that need to close before the product can go on shelf or into channel, written for a leadership team, a board, or an investor without further translation.